The efficacy and tolerability of glucosamine sulfate in the treatment of knee osteoarthritis: A randomized, double-blind, placebo-controlled trial.

[1]  B. Koes,et al.  Effect of Glucosamine Sulfate on Hip Osteoarthritis , 2008, Annals of Internal Medicine.

[2]  M. Locatelli,et al.  Synovial and plasma glucosamine concentrations in osteoarthritic patients following oral crystalline glucosamine sulphate at therapeutic dose. , 2007, Osteoarthritis and cartilage.

[3]  G. Herrero-Beaumont,et al.  Glucosamine sulfate in the treatment of knee osteoarthritis symptoms: a randomized, double-blind, placebo-controlled study using acetaminophen as a side comparator. , 2007, Arthritis and rheumatism.

[4]  J. Emberson,et al.  Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials , 2006, BMJ : British Medical Journal.

[5]  G. Verbruggen.  Chondroprotective drugs in degenerative joint diseases. , 2006, Rheumatology.

[6]  M. Locatelli,et al.  Glucosamine oral bioavailability and plasma pharmacokinetics after increasing doses of crystalline glucosamine sulfate in man. , 2005, Osteoarthritis and cartilage.

[7]  T. Schnitzer,et al.  Efficacy of rofecoxib, celecoxib, and acetaminophen in patients with osteoarthritis of the knee. A combined analysis of the VACT studies. , 2005, The Journal of rheumatology.

[8]  J. Caron,et al.  Glucosamine and chondroitin sulfate regulate gene expression and synthesis of nitric oxide and prostaglandin E(2) in articular cartilage explants. , 2005, Osteoarthritis and cartilage.

[9]  V. Welch,et al.  Glucosamine therapy for treating osteoarthritis. , 2005, The Cochrane database of systematic reviews.

[10]  C. Lines,et al.  Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. , 2005, The New England journal of medicine.

[11]  G. Koch,et al.  Patient preference in a crossover clinical trial of patients with osteoarthritis of the knee or hip: face validity of self-report questionnaire ratings. , 2005, The Journal of rheumatology.

[12]  M. Doherty,et al.  Does paracetamol (acetaminophen) reduce the pain of osteoarthritis?: a meta-analysis of randomised controlled trials , 2004, Annals of the rheumatic diseases.

[13]  Arden,et al.  EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT) , 2003, Annals of the rheumatic diseases.

[14]  F. Salaffi,et al.  Reliability and validity of the Western Ontario and McMaster Universities (WOMAC) Osteoarthritis Index in Italian patients with osteoarthritis of the knee. , 2003, Osteoarthritis and cartilage.

[15]  S. Jimenez,et al.  Glucosamine sulfate modulates the levels of aggrecan and matrix metalloproteinase-3 synthesized by cultured human osteoarthritis articular chondrocytes. , 2003, Osteoarthritis and cartilage.

[16]  G. Herrero-Beaumont,et al.  Glucosamine inhibits IL-1β-induced NFκB activation in human osteoarthritic chondrocytes , 2003 .

[17]  K. Pavelka,et al.  Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study. , 2002, Archives of internal medicine.

[18]  P. Shekelle,et al.  A metaanalysis of severe upper gastrointestinal complications of nonsteroidal antiinflammatory drugs. , 2002, The Journal of rheumatology.

[19]  M. Baron,et al.  Sulfate could mediate the therapeutic effect of glucosamine sulfate. , 2001, Metabolism: clinical and experimental.

[20]  R. Reddy,et al.  Preferential incorporation of glucosamine into the galactosamine moieties of chondroitin sulfates in articular cartilage explants. , 2001, Arthritis and rheumatism.

[21]  R. McCarney,et al.  Knee pain and osteoarthritis in older adults: a review of community burden and current use of primary health care , 2001, Annals of the rheumatic diseases.

[22]  Eric Lejeune,et al.  Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial , 2001, The Lancet.

[23]  M. Dougados,et al.  Response criteria for clinical trials on osteoarthritis of the knee and hip: a report of the Osteoarthritis Research Society International Standing Committee for Clinical Trials response criteria initiative. , 2000, Osteoarthritis and cartilage.

[24]  J. Bolognese,et al.  Rofecoxib, a specific inhibitor of cyclooxygenase 2, with clinical efficacy comparable with that of diclofenac sodium: results of a one-year, randomized, clinical trial in patients with osteoarthritis of the knee and hip. Rofecoxib Phase III Protocol 035 Study Group. , 2000, Arthritis and rheumatism.

[25]  D. Felson,et al.  Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis. , 2000, JAMA.

[26]  P. Franchimont,et al.  Stimulation of proteoglycan production by glucosamine sulfate in chondrocytes isolated from human osteoarthritic articular cartilage in vitro. , 1998, Osteoarthritis and cartilage.

[27]  Nicholas Bellamy,et al.  Design and conduct of clinical trials in patients with osteoarthritis : Recommendations from a task force of the Osteoarthritic Research Society , 1996 .

[28]  T. Spector,et al.  Recommendations for the registration of drugs used in the treatment of osteoarthritis. Group for the respect of ethics and excellence in science (GREES): osteoarthritis section. , 1996, Annals of the rheumatic diseases.

[29]  A. Baron,et al.  Glucosamine induces insulin resistance in vivo by affecting GLUT 4 translocation in skeletal muscle. Implications for glucose toxicity. , 1995, The Journal of clinical investigation.

[30]  J. Whitehead,et al.  Effects of antiinflammatory drugs on the progression of osteoarthritis of the knee. LINK Study Group. Longitudinal Investigation of Nonsteroidal Antiinflammatory Drugs in Knee Osteoarthritis. , 1995, The Journal of rheumatology.

[31]  K. Brandt.  Toward Pharmacologic Modification of Joint Damage in Osteoarthritis , 1995, Annals of Internal Medicine.

[32]  M. Fischer,et al.  Glucosamine sulfate in osteoarthritis of the knee. , 1994, Osteoarthritis and cartilage.

[33]  C. Goldsmith,et al.  Prior score availability: observations using the WOMAC osteoarthritis index. , 1991, British journal of rheumatology.

[34]  R. Moskowitz,et al.  Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. , 1986, Arthritis and rheumatism.

[35]  J. Kellgren,et al.  Radiological Assessment of Osteo-Arthrosis , 1957, Annals of the rheumatic diseases.

[36]  J. Elisseeff,et al.  Glucosamine modulates chondrocyte proliferation, matrix synthesis, and gene expression. , 2007, Osteoarthritis and cartilage.

[37]  P. Richette,et al.  Structure-modifying agents for osteoarthritis: an update. , 2004, Joint, bone, spine : revue du rhumatisme.